SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sudarshan Phani, Michael Jablonski, Josh Pelta-Heller, Jingli Cai, Lorraine Iacovitti, Gremlin is a novel VTA derived neuroprotective factor for dopamine neurons, Brain Research, 2013, 1500, 88

    CrossRef

  2. 2
    Mickael Decressac, Nikolaos Volakakis, Anders Björklund, Thomas Perlmann, NURR1 in Parkinson disease—from pathogenesis to therapeutic potential, Nature Reviews Neurology, 2013, 9, 11, 629

    CrossRef

  3. 3
    Jeffrey H. Kordower, Anders Bjorklund, Trophic Factor Gene Therapy for Parkinson's Disease, Movement Disorders, 2013, 28, 1
  4. 4
    Merja H. Voutilainen, Susanne Bäck, Johan Peränen, Päivi Lindholm, Atso Raasmaja, Pekka T. Männistö, Mart Saarma, Raimo K. Tuominen, Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease, Experimental Neurology, 2011, 228, 1, 99

    CrossRef

  5. 5
    Miu Fei Lam, Meghan G. Thomas, Christopher R.P. Lind, Neurosurgical convection-enhanced delivery of treatments for Parkinson’s disease, Journal of Clinical Neuroscience, 2011, 18, 9, 1163

    CrossRef

  6. 6
    Aideen M. Sullivan, André Toulouse, Neurotrophic factors for the treatment of Parkinson's disease, Cytokine & Growth Factor Reviews, 2011, 22, 3, 157

    CrossRef

  7. 7
    B. Mertens, A. Massie, Y. Michotte, S. Sarre, Effect of nigrostriatal damage induced by 6-hydroxydopamine on the expression of glial cell line–derived neurotrophic factor in the striatum of the rat, Neuroscience, 2009, 162, 1, 148

    CrossRef

  8. 8
    Lukas Andereggen, Morten Meyer, Raphael Guzman, Angélique D. Ducray, Hans Rudolf Widmer, Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease, Brain Research, 2009, 1276, 39

    CrossRef

  9. 9
    Sebastien Carnicella, Dorit Ron, GDNF — A potential target to treat addiction, Pharmacology & Therapeutics, 2009, 122, 1, 9

    CrossRef

  10. 10
    Niklas Lindgren, Rehana K. Leak, Kirsten M. Carlson, Amanda D. Smith, Michael J. Zigmond, Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease, Journal of Neuroscience Research, 2008, 86, 9
  11. 11
    Tomoyo Hashimoto, Katsunori Nishi, Jun Nagasao, Sadatoshi Tsuji, Kiyomitsu Oyanagi, Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons, Brain Research, 2008, 1197, 143

    CrossRef

  12. 12
    R Grondin, Z Zhang, Y Ai, J Slevint, A.B. Young, D.M. Gash, G.A. Gerhardt, CNS Regeneration, 2008,

    CrossRef

  13. 13
    Myriam Escobar-Khondiker, Damien Toulorge, Serge Guerreiro, Etienne C. Hirsch, Patrick P. Michel, Parkinson's Disease, 2008,

    CrossRef

  14. 14
    M. Kameda, T. Shingo, K. Takahashi, K. Muraoka, K. Kurozumi, T. Yasuhara, T. Maruo, T. Tsuboi, T. Uozumi, T. Matsui, Y. Miyoshi, H. Hamada, I. Date, Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia, European Journal of Neuroscience, 2007, 26, 6
  15. 15
    L. Borgal, M. Hong, D. Sadi, I. Mendez, Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro, Neuroscience, 2007, 147, 3, 712

    CrossRef

  16. 16
    E. Garbayo, E. Ansorena, J.L. Lanciego, M.S. Aymerich, M.J. Blanco-Prieto, Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor, International Journal of Pharmaceutics, 2007, 344, 1-2, 9

    CrossRef

  17. 17
    Michael J. O'Neill, Marcus J. Messenger, Viktor Lakics, Tracey K. Murray, Eric H. Karran, Philip G. Szekeres, Eric S. Nisenbaum, Kalpana M. Merchant, The Pharmacology of Neurogenesis and Neuroenhancement, 2007,

    CrossRef

  18. 18
    Don M. Gash, Yan Chen, Greg Gerhardt, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  19. 19
    M. McLeod, M. Hong, K. Mukhida, D. Sadi, R. Ulalia, I. Mendez, Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease, European Journal of Neuroscience, 2006, 24, 2
  20. 20
    Angélique Ducray, Sandra H. Krebs, Benoît Schaller, Rolf W. Seiler, Morten Meyer, Hans R. Widmer, GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon, Brain Research, 2006, 1069, 1, 104

    CrossRef

  21. 21
    Chih C. Chao, Cheng H. Chiang, Yun L. Ma, Eminy H.Y. Lee, Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: role of protein kinase CK2, Neurobiology of Aging, 2006, 27, 1, 105

    CrossRef

  22. 22
    Chi-Hsin Lin, Fu-Chou Cheng, Yen-Zhen Lu, Lan-Feng Chu, Chen-Hsuan Wang, Chi-Mei Hsueh, Protection of ischemic brain cells is dependent on astrocyte-derived growth factors and their receptors, Experimental Neurology, 2006, 201, 1, 225

    CrossRef

  23. 23
    Shubhayu Basu, Shang-Tian Yang, Astrocyte Growth and Glial Cell Line-Derived Neurotrophic Factor Secretion in Three-Dimensional Polyethylene Terephthalate Fibrous Matrices, Tissue Engineering, 2005, 11, 5-6, 940

    CrossRef

  24. 24
    B. Jakobsen, J. B. Gramsbergen, A. Møller Dall, C. Rosenblad, J. Zimmer, Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP+ toxicity by GDNF, European Journal of Neuroscience, 2005, 21, 11
  25. 25
    Terri K. Wood, Kieran W. McDermott, Aideen M. Sullivan, Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain, Journal of Neuroscience Research, 2005, 80, 6
  26. 26
    Benoît Schaller, Robert H. Andres, Alexander W. Huber, Morten Meyer, Alberto Pérez-Bouza, Angélique D. Ducray, Rolf W. Seiler, Hans R. Widmer, Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons, Brain Research, 2005, 1036, 1-2, 163

    CrossRef

  27. 27
    John T. Slevin, Greg A. Gerhardt, Charles D. Smith, Don M. Gash, Richard Kryscio, Byron Young, Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line—derived neurotrophic factor, Journal of Neurosurgery, 2005, 102, 2, 216

    CrossRef

  28. 28
    Yen-Zhen Lu, Chi-Hsin Lin, Fu-Chou Cheng, Chi-Mei Hsueh, Molecular mechanisms responsible for microglia-derived protection of Sprague–Dawley rat brain cells during in vitro ischemia, Neuroscience Letters, 2005, 373, 2, 159

    CrossRef

  29. 29
    Karin B. Zihlmann, Angélique D. Ducray, Benoît Schaller, Alexander W. Huber, Sandra H. Krebs, Robert H. Andres, Rolf W. Seiler, Morten Meyer, Hans R. Widmer, The GDNF family members neurturin, artemin and persephin promote the morphological differentiation of cultured ventral mesencephalic dopaminergic neurons, Brain Research Bulletin, 2005, 68, 1-2, 42

    CrossRef

  30. 30
    Yun Min Ding, Juliann D. Jaumotte, Armando P. Signore, Michael J. Zigmond, Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor, Journal of Neurochemistry, 2004, 89, 3
  31. 31
    Gerard W. O’Keeffe, Peter Dockery, Aideen M. Sullivan, Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro, Journal of Neurocytology, 2004, 33, 5, 479

    CrossRef

  32. 32
    Gilbert A. Lee, Chi-Hsin Lin, Hang-Hsiang Jiang, Hsin-Ju Chao, Chieh-Liang Wu, Chi-Mei Hsueh, Microglia-derived glial cell line-derived neurotrophic factor could protect Sprague–Dawley rat astrocyte from in vitro ischemia-induced damage, Neuroscience Letters, 2004, 356, 2, 111

    CrossRef

  33. 33
    Martha C. Bohn, Motoneurons crave glial cell line-derived neurotrophic factor, Experimental Neurology, 2004, 190, 2, 263

    CrossRef

  34. 34
    Takao Yasuhara, Tetsuro Shingo, Kazuki Kobayashi, Akira Takeuchi, Akimasa Yano, Kenichiro Muraoka, Toshihiro Matsui, Yasuyuki Miyoshi, Hirofumi Hamada, Isao Date, Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease, European Journal of Neuroscience, 2004, 19, 6
  35. 35
    Amanda D Smith, Marci Antion, Michael J Zigmond, Mark C Austin, Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRα1 and RET mRNAs in the adult rat, Molecular Brain Research, 2003, 117, 2, 129

    CrossRef

  36. 36
    Mariko Nishiguchi, Kimiko Tokugawa, Kyoko Yamamoto, Tomoko Akama, Yuriko Nozawa, Shigeyuki Chaki, Tomokazu Ueki, Kazuya Kameo, Shigeru Okuyama, Increase in secretion of glial cell line-derived neurotrophic factor from glial cell lines by inhibitors of vacuolar ATPase, Neurochemistry International, 2003, 42, 6, 493

    CrossRef

  37. 37
    Kimiko Tokugawa, Kyoko Yamamoto, Mariko Nishiguchi, Takumi Sekine, Masahiko Sakai, Tomokazu Ueki, Shigeyuki Chaki, Shigeru Okuyama, XIB4035, a novel nonpeptidyl small molecule agonist for GFRα-1, Neurochemistry International, 2003, 42, 1, 81

    CrossRef

  38. 38
    Hengyi Xiao, Yoko Hirata,,, Ken-ichi Isobe, Kazutoshi Kiuchi, Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines, Journal of Neurochemistry, 2002, 82, 4
  39. 39
    Ole Isacson, Models of repair mechanisms for future treatment modalities of Parkinson’s disease, Brain Research Bulletin, 2002, 57, 6, 839

    CrossRef

  40. 40
    Emilce Carrasco, Peter Werner, Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+: protection by acetylsalicylic acid (aspirin), Parkinsonism & Related Disorders, 2002, 8, 6, 407

    CrossRef

  41. 41
    Hiroyuki Miyazaki, Kazuo Nagashima, Yasunobu Okuma, Yasuyuki Nomura, Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats, Brain Research, 2001, 922, 2, 165

    CrossRef

  42. 42
    Timo Stöver, Young-Jae Nam, Tzy-Wen L. Gong, Margaret I. Lomax, Richard A. Altschuler, Glial cell line-derived neurotrophic factor (GDNF) and its receptor complex are expressed in the auditory nerve of the mature rat cochlea, Hearing Research, 2001, 155, 1-2, 143

    CrossRef

  43. 43
    Spyridon Theofilopoulos, Julian Goggi, Samina S Riaz, Eric Jauniaux, Gerald M Stern, Henry F Bradford, Parallel induction of the formation of dopamine and its metabolites with induction of tyrosine hydroxylase expression in foetal rat and human cerebral cortical cells by brain-derived neurotrophic factor and glial-cell derived neurotrophic factor, Developmental Brain Research, 2001, 127, 2, 111

    CrossRef

  44. 44
    Timo Stöver, Tzy-Wen L Gong, Younsook Cho, Richard A Altschuler, Margaret I Lomax, Expression of the GDNF family members and their receptors in the mature rat cochlea, Molecular Brain Research, 2000, 76, 1, 25

    CrossRef

  45. 45
    Hans R. Widmer, Benoıt Schaller, Morten Meyer, Rolf W. Seiler, Glial Cell Line-Derived Neurotrophic Factor Stimulates the Morphological Differentiation of Cultured Ventral Mesencephalic Calbindin- and Calretinin-Expressing Neurons, Experimental Neurology, 2000, 164, 1, 71

    CrossRef

  46. 46
    Masato Horie, Yasuhide Mitsumoto, Hiroyuki Kyushiki, Naohide Kanemoto, Akihito Watanabe, Yoshihiro Taniguchi, Naoki Nishino, Takashi Okamoto, Mari Kondo, Toyoki Mori, Koichi Noguchi, Yusuke Nakamura, Ei-ichi Takahashi, Akira Tanigami, Identification and Characterization of TMEFF2, a Novel Survival Factor for Hippocampal and Mesencephalic Neurons, Genomics, 2000, 67, 2, 146

    CrossRef

  47. 47
    L.C. Costantini, O. Isacson, Immunophilin Ligands and GDNF Enhance Neurite Branching or Elongation from Developing Dopamine Neurons in Culture, Experimental Neurology, 2000, 164, 1, 60

    CrossRef

  48. 48
    Morten Meyer, Jens Johansen, Jan-Bert Gramsbergen, Teit E. Johansen, Jens Zimmer, Improved Survival of Embryonic Porcine Dopaminergic Neurons in Coculture with a Conditionally Immortalized GDNF-Producing Hippocampal Cell Line, Experimental Neurology, 2000, 164, 1, 82

    CrossRef

  49. 49
    D.W. Howells, M.J. Porritt, J.Y.F. Wong, P.E. Batchelor, R. Kalnins, A.J. Hughes, G.A. Donnan, Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra, Experimental Neurology, 2000, 166, 1, 127

    CrossRef

  50. 50
    Nicole Deglon, Jack L. Tseng, Jean-Charles Bensadoun, Anne D. Zurn, Yvan Arsenijevic, Luis Pereira De Almeida, Romain Zufferey, Didier Trono, Patrick Aebischer, Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's Disease, Human Gene Therapy, 2000, 11, 1, 179

    CrossRef

  51. 51
    Michael D Doherty, Virginia M Pickel, Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area, Brain Research, 2000, 864, 2, 176

    CrossRef

  52. 52
    Young-Jae Nam, Timo Stöver, Sharon S. Hartman, Richard A. Altschuler, Upregulation of glial cell line-derived neurotrophic factor (GDNF) in the rat cochlea following noise, Hearing Research, 2000, 146, 1-2, 1

    CrossRef

  53. 53
    George M. Smith, Mario I. Romero, Adenoviral-mediated gene transfer to enhance neuronal survival, growth, and regeneration, Journal of Neuroscience Research, 1999, 55, 2
  54. 54
    Akira Hattori, Masahiro Katayama, Shoji Iwasaki, Kazuhiro Ishii, Masafumi Tsujimoto, Michiaki Kohno, Bone Morphogenetic Protein-2 Promotes Survival and Differentiation of Striatal GABAergic Neurons in the Absence of Glial Cell Proliferation, Journal of Neurochemistry, 1999, 72, 6
  55. 55
    Vivek Mehta, Murray Hong, Julian Spears, Ivar Mendez, Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor, Neurosurgical FOCUS, 1999, 7, 3, E6

    CrossRef

  56. 56
    Tomoaki Ikeda, Xiao Y Xia, Yi X Xia, Tsuyomu Ikenoue, Ben H Choi, Expression of glial cell line-derived neurotrophic factor in the brain and cerebrospinal fluid of the developing rat, International Journal of Developmental Neuroscience, 1999, 17, 7, 681

    CrossRef

  57. 57
    Elliot Krames, Eric Buchser, Samuel J Hassenbusch, Robert Levy, Future Trends in the Development of Local Drug Delivery Systems: Intraspinal, Intracerebral, and Intraparenchymal Therapies, Neuromodulation: Technology at the Neural Interface, 1999, 2, 2
  58. 58
    Brian C Kramer, Abraham D Goldman, Catherine Mytilineou, Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro, Brain Research, 1999, 851, 1-2, 221

    CrossRef

  59. 59
    Masao Yagi, Ella Magal, Zeqi Sheng, Kathleen A. Ang, Yehoash Raphael, Hair Cell Protection from Aminoglycoside Ototoxicity by Adenovirus-Mediated Overexpression of Glial Cell Line-Derived Neurotrophic Factor, Human Gene Therapy, 1999, 10, 5, 813

    CrossRef

  60. 60
    Chad J. Messer, Jin H. Son, Tong H. Joh, Klaus D. Beck, Eric J. Nestler, Regulation of tyrosine hyroxylase gene transcription in ventral midbrain by glial cell line-derived neurotrophic factor, Synapse, 1999, 34, 3
  61. 61
    Meleik A. Hebert, Barry J. Hoffer, Zhiming Zhang, Wayne A. Cass, Alexander F. Hoffman, Don M. Gash, Greg A. Gerhardt, CNS Regeneration, 1999,

    CrossRef

  62. 62
    J. C. Bensadoun, O. Mirochnitchenko, M. Inouye, P. Aebischer, A. D. Zurn, Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice, European Journal of Neuroscience, 1998, 10, 10
  63. 63
    Kaspar Zimmermann, Bastian Hengerer, Design and synthesis of a biotinylated dopamine transporter ligand for the purification and labeling of dopaminergic neurons, Bioorganic & Medicinal Chemistry Letters, 1998, 8, 3, 261

    CrossRef

  64. 64
    Vivek Mehta, Murray Hong, Julian Spears, Ivar Mendez, Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line—derived neurotrophic factor, Journal of Neurosurgery, 1998, 88, 6, 1088

    CrossRef

  65. 65
    Douglas G. Walker, Thomas G. Beach, Ren Xu, Jack Lile, Klaus D. Beck, Edith G. McGeer, Patrick L. McGeer, Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease, Brain Research, 1998, 792, 2, 207

    CrossRef

  66. 66
    Samer Tabbal, Stanley Fahn, Steven Frucht, Fetal tissue transplanation in Parkinson’s disease, Current Opinion in Neurology, 1998, 11, 4, 341

    CrossRef

  67. 67
    C Apostolides, E Sanford, M Hong, I Mendez, Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells, Neuroscience, 1998, 83, 2, 363

    CrossRef

  68. 68
    Nobuyuki Takei, Ylva Skoglösa, Dan Lindholm, Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (pACAP) on mesencephalic dopaminergic neurons, Journal of Neuroscience Research, 1998, 54, 5
  69. 69
    Ali Samii, Shallen R. Letwin, Donald B. Calne, Prospects for new drug treatment in idiopathic parkinsonism, Drug Discovery Today, 1998, 3, 3, 131

    CrossRef

  70. 70
    B Connor, M Dragunow, The role of neuronal growth factors in neurodegenerative disorders of the human brain, Brain Research Reviews, 1998, 27, 1, 1

    CrossRef

  71. 71
    K.E. van Esseveldt, R. Liu, W.T.J.M.C. Hermens, J. Verhaagen, G.J. Boer, Adenoviral vector-mediated gene transfer and neurotransplantation: possibilities and limitations in grafting of the fetal rat suprachiasmatic nucleus, Journal of Neuroscience Methods, 1997, 71, 1, 113

    CrossRef

  72. 72
    H.K. Raymon, S. Thode, F.H. Gage, Application ofex VivoGene Therapy in the Treatment of Parkinson's Disease, Experimental Neurology, 1997, 144, 1, 82

    CrossRef

  73. 73
    G.N. Kryzhanovsky, V.G. Kucheryanu, O.M. Pozdnyakov, E.B. Kladkevich, N.A. Krupina, E.V. Nikushkin, Y. Oomura, Effects of fibroblast growth factors on MPTP-induced parkinsonian syndrome in mice, Pathophysiology, 1997, 4, 1, 59

    CrossRef

  74. 74
    Paul A. Lapchak, Don M. Gash, Shoushu Jiao, Paul J. Miller, Dana Hilt, Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's Disease, Experimental Neurology, 1997, 144, 1, 29

    CrossRef

  75. 75
    A. Bilang-Bleuel, F. Revah, P. Colin, I. Locquet, J.-J. Robert, J. Mallet, P. Horellou, Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease, Proceedings of the National Academy of Sciences, 1997, 94, 16, 8818

    CrossRef

  76. 76
    R. J. Mandel, S. K. Spratt, R. O. Snyder, S. E. Leff, Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats, Proceedings of the National Academy of Sciences, 1997, 94, 25, 14083

    CrossRef

  77. 77
    Paul A. Lapchak, Don M. Gash, F. Collins, Dana Hilt, Paul J. Miller, Dalia M. Araujo, Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease, Experimental Neurology, 1997, 145, 2, 309

    CrossRef

  78. 78
    Dwaine F. Ernerich, Melissa Plone, Johnathan Francis, Beata R. Frydel, Shelley R. Winn, Mark D. Lindner, Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts, Brain Research, 1996, 736, 1-2, 99

    CrossRef

  79. 79
    Jyh-Gong Gabriel Hou, Catherine Mytilineou, Secretion of GDNF by glial cells does not account for the neurotrophic effect of bFGF on dopamine neurons in vitro, Brain Research, 1996, 724, 1, 145

    CrossRef

  80. 80
    Jeffrey M. Tosk, Mina Farag, Jennifer Y. Ho, Charles C. Lee, Bassem B. Maximos, Hung-Hei Yung, The effects of nerve growth factor and ganglioside GM1 on the anti-proliferative activity of cocaine in PC 12 cells, Life Sciences, 1996, 59, 20, 1731

    CrossRef

  81. 81
    K.Noelle Gracy, Virginia M Pickel, Ultrastructural immunocytochemical localization of the N-methyl-d-aspartate receptor and tyrosine hydroxylase in the shell of the rat nucleus accumbens, Brain Research, 1996, 739, 1-2, 169

    CrossRef